Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan
· Delayed Price · Currency is JPY 44.00
+1.00 (2.33%)
Jun 13, 2025, 3:30 PM JST
TYO:4596 Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1,264 | 1,454 | 2,767 | 4,048 | 3,977 | 2,533 | Upgrade
|
| Cash & Short-Term Investments | 1,264 | 1,454 | 2,767 | 4,048 | 3,977 | 2,533 | Upgrade
|
| Cash Growth | -48.47% | -47.45% | -31.64% | 1.79% | 57.01% | -39.57% | Upgrade
|
| Accounts Receivable | 5.32 | 5 | 1 | 3 | - | - | Upgrade
|
| Other Receivables | - | - | - | 1 | - | 6 | Upgrade
|
| Receivables | 5.32 | 5 | 1 | 4 | - | 6 | Upgrade
|
| Inventory | 9.97 | 10 | 36 | 7 | - | - | Upgrade
|
| Prepaid Expenses | - | 27 | 39 | 99 | 187 | 74 | Upgrade
|
| Other Current Assets | 62.86 | 35 | 26 | 23 | 461 | 3,804 | Upgrade
|
| Total Current Assets | 1,342 | 1,531 | 2,869 | 4,181 | 4,625 | 6,417 | Upgrade
|
| Property, Plant & Equipment | - | - | 129 | 203 | 192 | 220 | Upgrade
|
| Long-Term Investments | - | 10 | 17 | 34 | 14 | 54 | Upgrade
|
| Other Long-Term Assets | 8.82 | - | 1 | 1 | 1 | - | Upgrade
|
| Total Assets | 1,351 | 1,541 | 3,016 | 4,419 | 4,832 | 6,691 | Upgrade
|
| Accounts Payable | 3.84 | 28 | 34 | 42 | 75 | 68 | Upgrade
|
| Accrued Expenses | 98.81 | 53 | 72 | 76 | 70 | 72 | Upgrade
|
| Current Portion of Leases | 16.39 | 10 | 55 | 39 | 62 | 139 | Upgrade
|
| Current Income Taxes Payable | - | 52 | 110 | 194 | 323 | 226 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 11 | - | Upgrade
|
| Other Current Liabilities | 5.78 | 8 | 11 | 9 | 1 | 1 | Upgrade
|
| Total Current Liabilities | 124.82 | 151 | 282 | 360 | 542 | 506 | Upgrade
|
| Long-Term Leases | 14.62 | - | 87 | 109 | 137 | 179 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | 1 | - | 13 | Upgrade
|
| Total Liabilities | 139.44 | 151 | 369 | 470 | 679 | 698 | Upgrade
|
| Common Stock | 71.96 | 33 | 2,141 | 2,066 | 1,308 | 1,148 | Upgrade
|
| Additional Paid-In Capital | 27,911 | 27,867 | 27,638 | 27,526 | 26,755 | 26,523 | Upgrade
|
| Retained Earnings | -25,315 | -25,056 | -25,670 | -24,180 | -22,164 | -19,548 | Upgrade
|
| Comprehensive Income & Other | -1,456 | -1,454 | -1,462 | -1,463 | -1,746 | -2,130 | Upgrade
|
| Shareholders' Equity | 1,212 | 1,390 | 2,647 | 3,949 | 4,153 | 5,993 | Upgrade
|
| Total Liabilities & Equity | 1,351 | 1,541 | 3,016 | 4,419 | 4,832 | 6,691 | Upgrade
|
| Total Debt | 31 | 10 | 142 | 148 | 199 | 318 | Upgrade
|
| Net Cash (Debt) | 1,233 | 1,444 | 2,625 | 3,900 | 3,778 | 2,215 | Upgrade
|
| Net Cash Growth | -46.78% | -44.99% | -32.69% | 3.23% | 70.56% | -43.49% | Upgrade
|
| Net Cash Per Share | 21.75 | 25.63 | 47.22 | 79.16 | 82.97 | 51.71 | Upgrade
|
| Filing Date Shares Outstanding | 58.4 | 57.83 | 56.27 | 54.96 | 45.86 | 45.15 | Upgrade
|
| Total Common Shares Outstanding | 58.4 | 56.77 | 56.06 | 54.62 | 45.86 | 44.56 | Upgrade
|
| Working Capital | 1,217 | 1,380 | 2,587 | 3,821 | 4,083 | 5,911 | Upgrade
|
| Book Value Per Share | 20.75 | 24.49 | 47.21 | 72.30 | 90.56 | 134.50 | Upgrade
|
| Tangible Book Value | 1,212 | 1,390 | 2,647 | 3,949 | 4,153 | 5,993 | Upgrade
|
| Tangible Book Value Per Share | 20.75 | 24.49 | 47.21 | 72.30 | 90.56 | 134.50 | Upgrade
|
| Order Backlog | - | - | 4.69 | 4.2 | - | - | Upgrade
|
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.